Literature DB >> 8783298

Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women.

G Jones1, C White, T Nguyen, P N Sambrook, P J Kelly, J A Eisman.   

Abstract

The aims of this study were to ascertain vertebral deformity prevalence in elderly men and women and to describe the association between bone mineral density (BMD) at the lumbar spine and femoral neck, severity of spinal degenerative disease and vertebral deformity prevalence. We performed standardized spinal radiographs in a random sample of 300 elderly men and women participating in the Dubbo Osteoporosis Epidemiology Study, a population-based study of fracture risk factors. Radiographs were read independently by masked observers for the prevalence of vertebral deformity and severity of osteophytosis. BMD was measured by dual-energy X-ray absorptiometry. The prevalence of vertebral deformities was critically dependent on the criterion used. The less strict criteria seemed to overestimate deformities at either end of the spine region analysed. However, irrespective of the criterion used, prevalence of deformity was higher in men than in women (25% vs 20% for the 3 SD criterion, 17% vs 12% for the 4 SD criterion and 27% vs 25% for the 25% criterion). Femoral neck BMD was more strongly associated with vertebral deformities than spinal BMD for the 25% criterion (OR/SD change in BMD 1.39 (p = 0.02) vs 1.20 (p = 0.19)), 3 SD criterion (OR/SD change in BMD 1.45 (p = 0.01) vs 1.10 (p = 0.34)) and 4 SD criterion (OR/SD change in BMD 1.98 (p = 0.0002) vs 1.68 (p = 0.008)). BMD was also more strongly associated with biconcave deformities than either wedge or crush deformities and more so in men than in women. Severity of spinal osteophytosis was not associated with vertebral deformity. In conclusion, femoral neck BMD is at least equivalent to the lumbar spine BMD in strength of association with prevalent vertebral fractures. Spinal osteophytosis falsely elevates BMD without a concomitant decrease in fracture risk, indicating that any interpretation of spinal BMD needs to be adjusted for osteophytosis. These findings support the use of femoral neck bone densitometry in older men and women. Moreover, these data indicate that current criteria for radiological assessment of vertebral deformity are sufficiently loose to include a substantial proportion of non-fractures in the elderly, with important implications for the design of clinical trials. However, irrespective of the criterion used, vertebral deformities in men are at least as common, if not more so, than in women, suggesting that vertebral osteoporotic fractures are overlooked in men.

Entities:  

Mesh:

Year:  1996        PMID: 8783298     DOI: 10.1007/bf01622740

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  22 in total

1.  Epidemiology of vertebral fractures in women.

Authors:  L J Melton; S H Kan; M A Frye; H W Wahner; W M O'Fallon; B L Riggs
Journal:  Am J Epidemiol       Date:  1989-05       Impact factor: 4.897

Review 2.  The relationship between osteoporosis and osteoarthritis.

Authors:  J Dequeker
Journal:  Clin Rheum Dis       Date:  1985-08

3.  Osteoporosis and back pain in the elderly. A controlled epidemiologic and radiographic study.

Authors:  C Zetterberg; S Mannius; D Mellstrom; A Rundgren; K Astrand
Journal:  Spine (Phila Pa 1976)       Date:  1990-08       Impact factor: 3.468

4.  Postural stability, falls and fractures in the elderly: results from the Dubbo Osteoporosis Epidemiology Study.

Authors:  S R Lord; P N Sambrook; C Gilbert; P J Kelly; T Nguyen; I W Webster; J A Eisman
Journal:  Med J Aust       Date:  1994-06-06       Impact factor: 7.738

5.  Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES).

Authors:  G Jones; T Nguyen; P N Sambrook; P J Kelly; C Gilbert; J A Eisman
Journal:  Osteoporos Int       Date:  1994-09       Impact factor: 4.507

6.  Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study.

Authors:  G Jones; T Nguyen; P Sambrook; P J Kelly; J A Eisman
Journal:  BMJ       Date:  1994-09-17

Review 7.  The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group.

Authors:  C Cooper; T O'Neill; A Silman
Journal:  Bone       Date:  1993       Impact factor: 4.398

8.  Thoracic spine compression fractures in Finland.

Authors:  M Härmä; M Heliövaara; A Aromaa; P Knekt
Journal:  Clin Orthop Relat Res       Date:  1986-04       Impact factor: 4.176

9.  Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis.

Authors:  T Masud; S Langley; P Wiltshire; D V Doyle; T D Spector
Journal:  BMJ       Date:  1993-07-17

10.  Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: the Chingford Study.

Authors:  T D Spector; E V McCloskey; D V Doyle; J A Kanis
Journal:  J Bone Miner Res       Date:  1993-07       Impact factor: 6.741

View more
  37 in total

1.  Vertebroplasty and balloon kyphoplasty in osteoporosis: friends or foes?

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

2.  Influence of baseline deformity definition on subsequent vertebral fracture risk in postmenopausal women.

Authors:  L J Melton; D E Wenger; E J Atkinson; S J Achenbach; T H Berquist; B L Riggs; G Jiang; R Eastell
Journal:  Osteoporos Int       Date:  2006-04-28       Impact factor: 4.507

3.  Bone mineral density and osteoporosis among a predominantly Caucasian elderly population in the city of São Paulo, Brazil.

Authors:  Marilia Brasilio Rodrigues Camargo; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Maria do Rosario Dias de Oliveira Latorre; Gabriela Luporini Saraiva; Andrea Lage; Nelson Carvalhaes Neto; Lara Miguel Quirino Araújo; José Gilberto H Vieira; Marise Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2005-02-12       Impact factor: 4.507

4.  Measurement of subregional vertebral bone mineral density in vitro using lateral projection dual-energy X-ray absorptiometry: validation with peripheral quantitative computed tomography.

Authors:  Andrew M Briggs; Egon Perilli; Ian H Parkinson; Susan Kantor; Tim V Wrigley; Nicola L Fazzalari; John D Wark
Journal:  J Bone Miner Metab       Date:  2011-09-13       Impact factor: 2.626

5.  [Vertebral deformity as an index of osteoporosis-induced spinal fracture--an external validity construct based on bone density data].

Authors:  C Scheidt-Nave; D Felsenberg; G Kragi; T Bruckner; G Leidig-Bruckner; C Wüster; R Ziegler
Journal:  Med Klin (Munich)       Date:  1998-03-15

6.  Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: a population-based study.

Authors:  N M van Schoor; J H Smit; J W R Twisk; P Lips
Journal:  Osteoporos Int       Date:  2004-10-12       Impact factor: 4.507

7.  Cross-geographic region differences in quality of life in women with and without vertebral fracture.

Authors:  N M van Schoor; H Yu; J Bobula; P Lips
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

8.  Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis.

Authors:  G Jiang; R Eastell; N A Barrington; L Ferrar
Journal:  Osteoporos Int       Date:  2004-04-08       Impact factor: 4.507

9.  Incidence and risk factors for osteoporotic vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The São Paulo Ageing & Health (SPAH) Study.

Authors:  D S Domiciano; L G Machado; J B Lopes; C P Figueiredo; V F Caparbo; L Takayama; R M Oliveira; P R Menezes; R M R Pereira
Journal:  Osteoporos Int       Date:  2014-08-05       Impact factor: 4.507

10.  Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians.

Authors:  E Kingwell; J C Prior; P A Ratner; S M Kennedy
Journal:  Osteoporos Int       Date:  2009-06-04       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.